Asset Details
MbrlCatalogueTitleDetail
Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway
/ alternative complement pathway
/ Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy
/ Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology
/ Antibodies, Monoclonal, Humanized - therapeutic use
/ Autoimmune Diseases - immunology
/ Autoimmune Diseases - therapy
/ Complement Factor D - antagonists & inhibitors
/ Complement Factor D - biosynthesis
/ Complement Factor D - deficiency
/ Complement Factor D - physiology
/ Complement Pathway, Alternative - drug effects
/ factor D
/ Geographic Atrophy - genetics
/ Geographic Atrophy - immunology
/ Hemoglobinuria, Paroxysmal - drug therapy
/ Hemoglobinuria, Paroxysmal - genetics
/ Hemoglobinuria, Paroxysmal - immunology
/ Humans
/ Kidney Diseases - immunology
/ Lectins
/ Oligonucleotides, Antisense - therapeutic use
/ Peptides, Cyclic - therapeutic use
/ Proteins